SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-14-064325
Filing Date
2014-10-31
Accepted
2014-10-31 16:31:04
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A v392711_10qa.htm 10-Q/A 573305
2 EXHIBIT 31.1 v392711_ex31-1.htm EX-31.1 11540
3 EXHIBIT 31.2 v392711_ex31-2.htm EX-31.2 11505
4 EXHIBIT 32.1 v392711_ex32-1.htm EX-32.1 4220
5 EXHIBIT 32.2 v392711_ex32-2.htm EX-32.2 4390
  Complete submission text file 0001144204-14-064325.txt   9675989

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mslp-20140630.xml EX-101.INS 1710236
7 XBRL TAXONOMY EXTENSION SCHEMA mslp-20140630.xsd EX-101.SCH 79661
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mslp-20140630_cal.xml EX-101.CAL 84173
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mslp-20140630_def.xml EX-101.DEF 456708
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mslp-20140630_lab.xml EX-101.LAB 526944
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mslp-20140630_pre.xml EX-101.PRE 529877
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-53166 | Film No.: 141186931
SIC: 2834 Pharmaceutical Preparations